Curative Biosciences
Patrick O’Donnell, President and CEO

Curative Biosciences Inc. is an emerging leader in the development of novel, proprietary biomaterial and biologic combination products for the repair and regeneration of orthopaedic injury. Curative Biosciences Inc. products arm surgeon customers with advanced technological treatment options for improved clinical outcomes.

Curative’s products integrate natural bone and cartilage forming peptide and small molecule therapeutics with osteostimulating matrices that expedite the bodys native tissue healing and regeneration processes. Curative believes its biologically-enhanced orthopaedic therapies can improve the quality of life for millions of patients undergoing orthopaedic surgical procedure.